---
title: "Two River and Vida Ventures Extend Track Record of Company Creation and Value Realization Following the Candid Therapeutics’ Acquisition by UCB | AKTS Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285008499.md"
description: "Two River and Vida Ventures Extend Track Record of Company Creation and Value Realization Following the Candid Therapeutics’ Acquisition by UCB | AKTS Stock News"
datetime: "2026-05-03T16:00:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285008499.md)
  - [en](https://longbridge.com/en/news/285008499.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285008499.md)
---

# Two River and Vida Ventures Extend Track Record of Company Creation and Value Realization Following the Candid Therapeutics’ Acquisition by UCB | AKTS Stock News

Two River and Vida Ventures Extend Track Record of Company Creation and Value Realization Following the Candid Therapeutics’ Acquisition by UCB | AKTS Stock News

### Related Stocks

- [UCBJY.US](https://longbridge.com/en/quote/UCBJY.US.md)
- [UCB.US](https://longbridge.com/en/quote/UCB.US.md)
- [AKTSQ.US](https://longbridge.com/en/quote/AKTSQ.US.md)
- [UCB.PRI.US](https://longbridge.com/en/quote/UCB.PRI.US.md)
- [UCB-I.US](https://longbridge.com/en/quote/UCB-I.US.md)

## Related News & Research

- [UCB reports positive outcomes for bimekizumab in psoriatic arthritis](https://longbridge.com/en/news/286906544.md)
- [<![CDATA[UCB Enters $2.2 Billion Agreement to Acquire Candid Therapeutics ]]>](https://longbridge.com/en/news/285081451.md)
- [United Community Banks Shareholders Back Directors and Governance](https://longbridge.com/en/news/286586173.md)
- [BRIEF-Jones Ventures Intl: Plans $200 Million IPO Of 20 Million Units - SEC Filing](https://longbridge.com/en/news/286549413.md)
- [BUZZ-Rallybio jumps as UCB steps in with $2.2 bln deal for Candid](https://longbridge.com/en/news/285055019.md)